Sclerosis News and Research

RSS

Study finds a lower rate of stroke among immigrants to Canada than long-term residents

Immigrants to Canada have a 33% lower rate of stroke than long-term residents, according to a study published in the August 18, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.

18 Aug 2021

Researchers develop new method to quantify protein droplets involved in neurodegenerative diseases

Some proteins in cells can separate into small droplets like oil droplets in water, but faults in this process may underlie neurodegenerative diseases in the brains of older people. Now, Rutgers researchers have developed a new method to quantify protein droplets involved in these diseases.

13 Aug 2021

‘I don’t want to risk my life for a paycheck’: Immunosuppressed people grapple with returning to work

Elizabeth Groenweghe got a kidney transplant 14 years ago. She now takes several medications to prevent her body from rejecting her transplant organ. But these medications also weaken her immune system, putting her at higher risk of becoming seriously ill if she catches covid-19.

13 Aug 2021

Pfizer CEO to public: Just trust us on the covid booster

Pfizer CEO Albert Bourla was confident in June about the ability of his company's vaccine to protect against the highly contagious delta variant, as it marched across the globe and filled U.S. hospitals with patients.

13 Aug 2021

Temple researchers receive $1.25M NIH grant to advance understanding of neurodegenerative diseases

Like wear and tear that causes electrical systems to short circuit, neurons in the human nervous system are susceptible to degenerative processes that disrupt the flow of information.

12 Aug 2021

Innovative therapeutic platform for blood-to-brain delivery of antisense oligonucleotide therapy

Antisense oligonucleotide (ASO) therapy has the potential to ameliorate many neurodegenerative diseases at the genetic level to suppress the production of harmful proteins or non-coding RNAs.

12 Aug 2021

Breakthrough SARS-CoV-2 infections in patients with systemic rheumatic diseases

A recent study discusses the clinical characteristics and outcomes of patients with SARDs who were previously vaccinated against SARS-CoV-2.

11 Aug 2021

CBD may reduce the adverse effects of anti-seizure drugs in people with epilepsy

Artisanal (non-pharmaceutical) cannabidiol (CBD) products have become popular in recent years for their apparent therapeutic effects. CBD — a naturally occurring compound of the cannabis plant legally derived from hemp — is used widely as a naturopathic remedy for a number of health conditions, including epilepsy and seizure disorders.

11 Aug 2021

MS Australia partners again with Jean Hailes to spotlight multiple sclerosis and women’s health

Multiple sclerosis affects around three times as many women as men and is commonly diagnosed between the ages of 20 and 40 years, when many women are focusing on career and family planning.

11 Aug 2021

Restoring cholesterol levels could be a new therapeutic approach for diseases linked to TDP-43 protein

Researchers in Singapore have discovered that brain cells cannot maintain the cholesterol-rich myelin sheath that protects and insulates neurons in the absence of a protein called TDP-43.

4 Aug 2021

Researchers discover potential biomarker for lung disease in scleroderma patients

Researchers have discovered a protein that may predict disease severity for a lung condition that often proves fatal to patients with scleroderma.

3 Aug 2021

Existing drug may be effective in treating SARS-CoV-2

Scientists from the University of Chicago have found that the drug masitinib may be effective in treating COVID-19.

2 Aug 2021

People with metabolic syndrome may be at higher risk for second stroke, death

People with larger waistlines, high blood pressure and other risk factors that make up metabolic syndrome may be at higher risk for having a second stroke and even dying than people who do not have metabolic syndrome, according to a meta-analysis published in the July 28, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.

28 Jul 2021

Foods high in flavonoids may lower risk of cognitive decline

A new study shows that people who eat a diet that includes at least half a serving per day of foods high in flavonoids like strawberries, oranges, peppers and apples may have a 20% lower risk of cognitive decline.

28 Jul 2021

Existing drug may be effective in treating COVID-19

A new University of Chicago study has found that the drug masitinib may be effective in treating COVID-19.

21 Jul 2021

Analysis: Necessary or not, covid booster shots are probably on the horizon

The drugmaker Pfizer recently announced that vaccinated people are likely to need a booster shot to be effectively protected against new variants of covid-19 and that the company would apply for Food and Drug Administration emergency use authorization for the shot.

21 Jul 2021

World Brain Day 2021: An interview with Professor Alan Thompson

In commemoration of World Brain Day 2021, News-Medical spoke to renowned neurology expert Professor Alan Thompson about his incredible career in brain research.

21 Jul 2021

Targeting Piezo1 protein may be a new and ideal strategy to cure multiple sclerosis

In a new University of California, Irvine-led study, researchers found that a certain protein prevented regulatory T cells (Tregs) from effectively doing their job in controlling the damaging effects of inflammation in a model of multiple sclerosis (MS), a devastating autoimmune disease of the nervous system.

20 Jul 2021

Novel robotic neck brace may help doctors to analyze neck mobility in cancer patients

A new robotic neck brace from researchers at Columbia Engineering and their colleagues at Columbia's Department of Otolaryngology may help doctors analyze the impact of cancer treatments on the neck mobility of patients and guide their recovery.

19 Jul 2021

New research may offer clues to why MS patients develop progressive disability

Did you know multiple sclerosis (MS) means multiple scars? New research shows that the brain and spinal cord scars in people with MS may offer clues to why they developprogressive disability but those with related diseases where the immune system attacks the central nervous system do not.

19 Jul 2021

Sclerosis News and Research

Study finds a lower rate of stroke among immigrants to Canada than long-term residents

Researchers develop new method to quantify protein droplets involved in neurodegenerative diseases

‘I don’t want to risk my life for a paycheck’: Immunosuppressed people grapple with returning to work

Pfizer CEO to public: Just trust us on the covid booster

Temple researchers receive $1.25M NIH grant to advance understanding of neurodegenerative diseases

Innovative therapeutic platform for blood-to-brain delivery of antisense oligonucleotide therapy

Breakthrough SARS-CoV-2 infections in patients with systemic rheumatic diseases

CBD may reduce the adverse effects of anti-seizure drugs in people with epilepsy

MS Australia partners again with Jean Hailes to spotlight multiple sclerosis and women’s health

Restoring cholesterol levels could be a new therapeutic approach for diseases linked to TDP-43 protein

Researchers discover potential biomarker for lung disease in scleroderma patients

Existing drug may be effective in treating SARS-CoV-2

People with metabolic syndrome may be at higher risk for second stroke, death

Foods high in flavonoids may lower risk of cognitive decline

Existing drug may be effective in treating COVID-19

Analysis: Necessary or not, covid booster shots are probably on the horizon

World Brain Day 2021: An interview with Professor Alan Thompson

Targeting Piezo1 protein may be a new and ideal strategy to cure multiple sclerosis

Novel robotic neck brace may help doctors to analyze neck mobility in cancer patients

New research may offer clues to why MS patients develop progressive disability

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News